Free Trial

Black Diamond Therapeutics (BDTX) SEC Filings & 10K Form

Black Diamond Therapeutics logo
$1.42 +0.02 (+1.43%)
Closing price 04:00 PM Eastern
Extended Trading
$1.41 -0.01 (-0.70%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Black Diamond Therapeutics SEC Filings

DateFilerForm TypeView
03/21/2025
3:19 PM
Behbahani Ali (Reporting)
Black Diamond Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
12:01 PM
BB BIOTECH AG (Filed by)
Black Diamond Therapeutics (Subject)
Form SCHEDULE 13G/A
03/20/2025
8:01 PM
BB BIOTECH AG (Reporting)
BIOTECH GROWTH N V (Reporting)
Black Diamond Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
6:08 AM
Black Diamond Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
1:36 PM
BB BIOTECH AG (Filed by)
Black Diamond Therapeutics (Subject)
Form SCHEDULE 13G/A
01/31/2025
3:35 PM
Black Diamond Therapeutics (Issuer)
Hatzis-Schoch Brent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
3:35 PM
Black Diamond Therapeutics (Issuer)
Jones Erika (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
3:36 PM
Black Diamond Therapeutics (Issuer)
Buck Elizabeth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
3:36 PM
Black Diamond Therapeutics (Issuer)
Yurasov Sergey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
3:37 PM
Black Diamond Therapeutics (Issuer)
Velleca Mark A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
4:09 PM
Behbahani Ali (Reporting)
Black Diamond Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:34 PM
Black Diamond Therapeutics (Issuer)
Campbell Shannon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:34 PM
Black Diamond Therapeutics (Issuer)
Raman Prakash (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
6:01 AM
Black Diamond Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
6:03 AM
Black Diamond Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/24/2024
1:02 PM
Black Diamond Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
09/23/2024
6:09 AM
Black Diamond Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
3:24 PM
Black Diamond Therapeutics (Issuer)
Raman Prakash (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
3:24 PM
Black Diamond Therapeutics (Issuer)
Campbell Shannon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
3:30 PM
Behbahani Ali (Reporting)
Black Diamond Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
3:16 PM
Black Diamond Therapeutics (Issuer)
Versant Vantage I, L.P. (Reporting)
Versant Venture Capital VI, L.P. (Reporting)
Versant Voyageurs I Parallel, L.P. (Reporting)
Versant Voyageurs I, L.P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
3:48 PM
Black Diamond Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
Form SC 13D/A
08/06/2024
6:00 AM
Black Diamond Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
6:04 AM
Black Diamond Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/26/2024
4:54 PM
Black Diamond Therapeutics (Subject)
Epstein David M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
3:51 PM
Black Diamond Therapeutics (Subject)
Epstein David M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/11/2024
3:31 PM
Black Diamond Therapeutics (Subject)
Epstein David M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2024
1:17 PM
Black Diamond Therapeutics (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
Form SC 13G/A
07/09/2024
3:30 PM
Black Diamond Therapeutics (Subject)
Epstein David M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/28/2024
4:44 PM
Black Diamond Therapeutics (Subject)
Epstein David M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/27/2024
4:06 PM
Black Diamond Therapeutics (Subject)
Epstein David M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2024
4:09 PM
Black Diamond Therapeutics (Subject)
Epstein David M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/21/2024
3:41 PM
Black Diamond Therapeutics (Subject)
Epstein David M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/21/2024
3:25 PM
Behbahani Ali (Reporting)
Black Diamond Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:28 PM
Black Diamond Therapeutics (Subject)
Epstein David M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/20/2024
3:28 PM
Black Diamond Therapeutics (Subject)
Epstein David M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2024
3:39 PM
Black Diamond Therapeutics (Subject)
Epstein David M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2024
3:11 PM
Black Diamond Therapeutics (Subject)
Epstein David M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/12/2024
3:12 PM
Black Diamond Therapeutics (Subject)
Epstein David M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2024
5:20 PM
Behbahani Ali (Reporting)
Black Diamond Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
4:50 PM
Black Diamond Therapeutics (Issuer)
Dhingra Kapil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps (Ad)

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.
06/06/2024
4:52 PM
Black Diamond Therapeutics (Issuer)
Campbell Shannon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
4:53 PM
Black Diamond Therapeutics (Issuer)
Raman Prakash (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
4:54 PM
Black Diamond Therapeutics (Issuer)
Menzel Garry E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
4:55 PM
Black Diamond Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
6:09 PM
Black Diamond Therapeutics (Subject)
New Enterprise Associates 16, L.P. (Filed by)
Form SC 13D/A
05/09/2024
7:48 PM
Black Diamond Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
05/09/2024
6:10 AM
Black Diamond Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
6:13 AM
Black Diamond Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2024
3:04 PM
Black Diamond Therapeutics (Filer)
Form ARS
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:BDTX) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners